Capital Adept
  • Politics
  • Investing
  • Stocks
  • Business
  • Politics
  • Investing
  • Stocks
  • Business

Capital Adept

Politics

Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

by admin April 4, 2025
April 4, 2025
Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

Dr. Mehmet Oz will serve as the next administrator of the Centers for Medicare and Medicaid Services after the full Senate voted along party lines to confirm his nomination on Thursday. 

The former daytime TV doctor turned politician will be in charge of nearly $1.5 trillion in federal healthcare spending. His duties will entail overseeing Medicare, Medicaid and the Children’s Health Insurance Program (CHIP), including directing decisions related to how the government covers procedures, hospital stays and medication, as well as the reimbursement rates at which healthcare providers get paid for their services.   

Medicare is a federal healthcare program for seniors aged 65 and up, and currently provides coverage to about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, a public health assistance program for people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov. Meanwhile, CHIP, which provides free or low-cost health coverage for eligible low-income children and family members, assists around 7.2 million individuals. 

A graduate of Harvard University, Oz received medical and business degrees from the University of Pennsylvania. He is a former heart surgeon who saw his fame rise through his appearances on daytime television, including ‘The Oprah Winfrey Show,’ and 13 seasons of ‘The Dr. Oz Show.’

Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He lost to John Fetterman, then the state’s lieutenant governor.

‘Dr. Oz has a strong desire to modernize CMS and encourage healthy lifestyles for all Americans, including by focusing on the underlying causes of chronic disease and implementing innovative technologies,’ Senate Finance Committee Chairman Sen. Mike Crapo, R-Idaho, said Thursday.

Crapo, who led Oz’s nomination process at the committee level, commended Oz for his ‘diligence and accessibility’ throughout the process, including his willingness to answer ‘hundreds’ of questions for the record.

Those questions came from both Republicans and Democrats. They included asking about Oz’s stance on abortion, transgender medical treatments, Medicare privatization, prescription drug pricing and more. Potential financial conflicts of interest were also a concern among Democratic lawmakers throughout Oz’s confirmation process. Oz has committed to divesting any holdings that may pose an issue. 

Thursday’s confirmation comes as the Trump administration continues to work to finalize the rest of its political appointments, including notably the president’s pick to be the next United Nations ambassador and his pick for director of the Consumer Financial Protection Bureau. 

Per The Washington Post’s ‘political appointee tracker,’ there are currently still 233 nominees being considered by the Senate.

This post appeared first on FOX NEWS

previous post
Trump urged to review UN immunity, lax visa rules amid national security concerns
next post
Bitcoin Holds Up, but Remains Short of Relative Breakout

Related Posts

I was Biden’s man in the room at...

March 21, 2025

PETA, animal rights groups praise Trump admin for...

April 14, 2025

Here’s what happened during Trump’s 10th week in...

March 30, 2025

Booker delivering marathon Senate speech against Trump admin,...

April 1, 2025

Trump allies mount campaign to get DOGE codified...

March 15, 2025

‘Biden effect’ hits the Senate: Wave of retirements...

April 25, 2025

Pentagon’s week of power struggles: Leak fallout and...

April 19, 2025

‘Shark Tank’ star insists AOC is a capitalist...

April 30, 2025

Trump plans to have annual physical exam later...

April 8, 2025

At least 26 American hostages released since Trump...

April 12, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      5 Strong Stocks Defying the Bearish Market!

      March 14, 2025
    • 2

      DP Trading Room: Market Sell-Off

      March 14, 2025
    • 3

      Sector Rotation Warning: More Downside Ahead for US Markets?

      March 14, 2025
    • 4

      The Best Five Sectors, #10

      March 14, 2025
    • 5

      Transform Your Investing Strategy: Uncover the 3 Game-Changing Rules

      March 14, 2025
    • 6

      Did Friday’s Reversal Mark A Major Bottom?

      March 14, 2025
    • 7

      CHARBONE Hydrogene et ABB signent une entente pour accelerer les usines de production d’hydrogene vert en Amerique du Nord

      March 14, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 capitaladept.com | All Rights Reserved